CALM vs CTVA: How Cal-Maine Foods and Corteva Compare (2026)

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CALM and CTVA share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CALM and CTVA exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Cal-Maine Foods is the largest producer of shell eggs in the United States by volume. The company sells approximately 1 billion dozen eggs annually, representing approximately 20% of US shell egg sales. Cal-Maine sells through grocery retailers, foodservice distributors, and other commercial customers, primarily across the southwestern and central US.

Full CALM guide

Corteva is one of the largest agricultural input companies in the world, formed in 2019 when DowDuPont spun off its agriculture business. The company operates two main segments. Seed develops and sells genetically improved corn, soybean, canola, and other crop seeds. Crop Protection develops and sells herbicides, insecticides, fungicides, and biological products to protect crops from weeds, insects, and diseases.

Full CTVA guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CALM drivers: Avian influenza and supply disruption; Cage-free transition.
• CTVA drivers: Seed technology pipeline; Biological products growth.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Avian influenza could eventually impact Cal-Maine facilities, creating direct production losses. For CTVA, commodity crop price cycles affect farmer purchasing power and Corteva revenue.

Pick CALM if you believe its drivers more; CTVA if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CALM and CTVA guides.

CALM. Cal-Maine's valuation analysis is dominated by cyclical considerations. Trailing P/E is uninformative because earnings swing materially with egg prices. Normalized earnings analysis (looking at average earnings across a full price cycle) is more useful. The dividend is formula-based and tracks earnings.

CTVA. Corteva trades at a premium to traditional chemicals and materials peers reflecting the pure-play agricultural input exposure, the durable seed franchise, and the biologicals growth story. The multiple compresses during commodity crop downturns when farmer income weakens.

Headline figures (approximate, early 2026): CALM shows revenue (ttm) ~$3 billion (varies materially with egg prices), operating margin Highly cyclical, 5-40% across cycles, net income (ttm) Highly cyclical, depends on price environment, eps (ttm) Cyclical; CTVA shows revenue (ttm) ~$17 billion, operating margin ~13%, net income (ttm) ~$1.5 billion, eps (ttm) ~$2.20.

CALM and CTVA are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CALM and CTVA exposure against your real portfolio. It is not an investment adviser.